FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Wants eSubmissions to Conform to Data Standards

[ Price : $8.95]

FDA says it has amended its electronic submission Technical Rejection Criteria for Study Data to require study data standards in c...

FDA Rejects Dynavax BLA on Heplisav-B

[ Price : $8.95]

FDA sends Dynavax Technologies a Complete Response Letter on its BLA for Heplisav-B [hepatitis B vaccine, recombinant (adjuvanted)...

FDA Clears CapsoVision Capsule Endoscope

[ Price : $8.95]

FDA clears a CapsoVision 510(k) for the CapsoCam Plus small bowel capsule endoscope system.

Debarment Order Against Edward Manookian

[ Price : $8.95]

Federal Register Notice: FDA issues a debarment order against Edward Manookian (also known as Ed Manning) based on a finding that ...

Novartis Gains Priority Review for Midostaurin in Leukemia

[ Price : $8.95]

FDA grants Novartis a priority review for an NDA for midostaurin, indicated for treating acute myeloid leukemia in newly-diagnosed...

Celebrex Passes FDA-ordered Safety Study: Pfizer

[ Price : $8.95]

Pfizer says that an FDA-ordered safety study of Pfizers arthritis drug Celebrex (celecoxib) demonstrated similar rates of cardiova...

Comments Sought on Biologic Deviation Reporting Extension

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on an OMB submission to extend an information collection on the Reporting of Biologica...

FDA Grants Seattle Genetics Breakthrough Status for Adcetris

[ Price : $8.95]

FDA grants Seattle Genetics a breakthrough therapy designation for Adcetris (brentuximab vedotin) for treating patients with CD30-...

Retrophin Gains FDA Agreement on Retrophin Phase 3 Trial

[ Price : $8.95]

Retrophin reaches an agreement with FDA under a Special Protocol Assessment for a Phase 3 clinical trial evaluating RE-024, an in...

Trump Transition Healthcare Team Shapes Up

[ Price : $8.95]

President-elect Donald Trump reportedly selected former HHS official Andrew Bremberg to lead the transition team for HHS.